Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:06:11 UTC |
---|
Update Date | 2021-09-14 14:59:53 UTC |
---|
HMDB ID | HMDB0060901 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Clozapine glucuronide |
---|
Description | Clozapine glucuronide is a metabolite of clozapine. Clozapine (sold as Clozaril, Gen-Clozapine in Canada, Azaleptin, Leponex, Fazaclo, Froidir; Denzapine, Zaponex in the UK; Klozapol in Poland, Clopine in Australia and New Zealand) is an atypical antipsychotic medication used in the treatment of schizophrenia, and is also used off-label in the treatment of bipolar disorder. Wyatt. R and Chew. (Wikipedia) |
---|
Structure | CN1CCN(CC1)C1=NC2=C(C=CC(Cl)=C2)N([C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)C(O)=O)C2=CC=CC=C12 InChI=1S/C24H27ClN4O6/c1-27-8-10-28(11-9-27)22-14-4-2-3-5-16(14)29(17-7-6-13(25)12-15(17)26-22)23-20(32)18(30)19(31)21(35-23)24(33)34/h2-7,12,18-21,23,30-32H,8-11H2,1H3,(H,33,34)/t18-,19-,20+,21-,23+/m1/s1 |
---|
Synonyms | Value | Source |
---|
4(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine | HMDB | 4(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine hydrochloride | HMDB | 4-(4-Chlorophenyl)-1-(4-(4--fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine | HMDB |
|
---|
Chemical Formula | C24H27ClN4O6 |
---|
Average Molecular Weight | 502.947 |
---|
Monoisotopic Molecular Weight | 502.161912323 |
---|
IUPAC Name | (2R,3R,4R,5S,6S)-6-[6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaen-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
Traditional Name | (2R,3R,4R,5S,6S)-6-[6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,9,11,13-heptaen-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1CCN(CC1)C1=NC2=C(C=CC(Cl)=C2)N([C@H]2O[C@H]([C@H](O)[C@@H](O)[C@@H]2O)C(O)=O)C2=CC=CC=C12 |
---|
InChI Identifier | InChI=1S/C24H27ClN4O6/c1-27-8-10-28(11-9-27)22-14-4-2-3-5-16(14)29(17-7-6-13(25)12-15(17)26-22)23-20(32)18(30)19(31)21(35-23)24(33)34/h2-7,12,18-21,23,30-32H,8-11H2,1H3,(H,33,34)/t18-,19-,20+,21-,23+/m1/s1 |
---|
InChI Key | YWWIDMPXCSUNRD-VZWAGXQNSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dibenzodiazepines. Dibenzodiazepines are compounds containing a dibenzodiazepine moiety, which consists of two benzene connected by diazepine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | Dibenzodiazepines |
---|
Direct Parent | Dibenzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - Dibenzodiazepine
- N-glucuronide
- Glucuronic acid or derivatives
- Hexose monosaccharide
- Alkyldiarylamine
- N-glycosyl compound
- Glycosyl compound
- 1,4-benzodiazepine
- N-alkylpiperazine
- N-methylpiperazine
- Beta-hydroxy acid
- Hydroxy acid
- Aryl halide
- Imidolactam
- Monosaccharide
- 1,4-diazinane
- Benzenoid
- Oxane
- Piperazine
- Pyran
- Aryl chloride
- Secondary alcohol
- Tertiary amine
- Tertiary aliphatic amine
- Amino acid
- Amino acid or derivatives
- Amidine
- Carboxylic acid amidine
- Carboxylic acid derivative
- Carboxylic acid
- Oxacycle
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Polyol
- Monocarboxylic acid or derivatives
- Hydrocarbon derivative
- Organic nitrogen compound
- Amine
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Carbonyl group
- Organooxygen compound
- Alcohol
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Clozapine glucuronide,1TMS,isomer #1 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O)C3=CC=CC=C23)CC1 | 4003.3 | Semi standard non polar | 33892256 | Clozapine glucuronide,1TMS,isomer #2 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O)C3=CC=CC=C23)CC1 | 4019.5 | Semi standard non polar | 33892256 | Clozapine glucuronide,1TMS,isomer #3 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C)C3=CC=CC=C23)CC1 | 4008.9 | Semi standard non polar | 33892256 | Clozapine glucuronide,1TMS,isomer #4 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O)C3=CC=CC=C23)CC1 | 3971.2 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TMS,isomer #1 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O)C3=CC=CC=C23)CC1 | 3932.1 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TMS,isomer #2 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O)C3=CC=CC=C23)CC1 | 3967.0 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TMS,isomer #3 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C)C3=CC=CC=C23)CC1 | 3964.4 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TMS,isomer #4 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O)C3=CC=CC=C23)CC1 | 3938.1 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TMS,isomer #5 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)C3=CC=CC=C23)CC1 | 3968.0 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TMS,isomer #6 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C)C3=CC=CC=C23)CC1 | 3923.6 | Semi standard non polar | 33892256 | Clozapine glucuronide,3TMS,isomer #1 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O)C3=CC=CC=C23)CC1 | 3926.1 | Semi standard non polar | 33892256 | Clozapine glucuronide,3TMS,isomer #2 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C)C3=CC=CC=C23)CC1 | 3923.1 | Semi standard non polar | 33892256 | Clozapine glucuronide,3TMS,isomer #3 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)C3=CC=CC=C23)CC1 | 3967.7 | Semi standard non polar | 33892256 | Clozapine glucuronide,3TMS,isomer #4 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)C3=CC=CC=C23)CC1 | 3914.9 | Semi standard non polar | 33892256 | Clozapine glucuronide,4TMS,isomer #1 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@@H]3O[Si](C)(C)C)C3=CC=CC=C23)CC1 | 3934.2 | Semi standard non polar | 33892256 | Clozapine glucuronide,1TBDMS,isomer #1 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O)C3=CC=CC=C23)CC1 | 4168.6 | Semi standard non polar | 33892256 | Clozapine glucuronide,1TBDMS,isomer #2 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)C3=CC=CC=C23)CC1 | 4185.6 | Semi standard non polar | 33892256 | Clozapine glucuronide,1TBDMS,isomer #3 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 4173.8 | Semi standard non polar | 33892256 | Clozapine glucuronide,1TBDMS,isomer #4 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O)C3=CC=CC=C23)CC1 | 4164.3 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TBDMS,isomer #1 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O)C3=CC=CC=C23)CC1 | 4239.4 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TBDMS,isomer #2 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)C3=CC=CC=C23)CC1 | 4260.1 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TBDMS,isomer #3 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 4251.0 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TBDMS,isomer #4 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)C3=CC=CC=C23)CC1 | 4242.7 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TBDMS,isomer #5 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O[Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 4254.1 | Semi standard non polar | 33892256 | Clozapine glucuronide,2TBDMS,isomer #6 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 4237.3 | Semi standard non polar | 33892256 | Clozapine glucuronide,3TBDMS,isomer #1 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O)C3=CC=CC=C23)CC1 | 4344.9 | Semi standard non polar | 33892256 | Clozapine glucuronide,3TBDMS,isomer #2 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@@H]3O[Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 4337.4 | Semi standard non polar | 33892256 | Clozapine glucuronide,3TBDMS,isomer #3 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O[Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 4376.9 | Semi standard non polar | 33892256 | Clozapine glucuronide,3TBDMS,isomer #4 | CN1CCN(C2=NC3=CC(Cl)=CC=C3N([C@H]3O[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]3O[Si](C)(C)C(C)(C)C)C3=CC=CC=C23)CC1 | 4339.4 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Clozapine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-000i-9007400000-3fffd28afaba2c0b6622 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clozapine glucuronide GC-MS (2 TMS) - 70eV, Positive | splash10-003r-9406056000-46e11934c02e232f6951 | 2017-10-06 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 10V, Positive-QTOF | splash10-0f79-0002970000-c24223d4da8e082ee1f5 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 20V, Positive-QTOF | splash10-002r-7207910000-c340c2dc5c205f11ef8a | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 40V, Positive-QTOF | splash10-056r-1049100000-0108f71fb5bb73f6598d | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 10V, Negative-QTOF | splash10-0udi-0105790000-24032d67472d4f026db4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 20V, Negative-QTOF | splash10-00mt-0009100000-8f12f643cd8f30000a17 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 40V, Negative-QTOF | splash10-056r-8429000000-d2e9d61785df0ee41385 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 10V, Negative-QTOF | splash10-0udi-0002090000-6d43836d87a5d53f2082 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 20V, Negative-QTOF | splash10-00or-1009000000-5cc0ad82ad74567f67a9 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 40V, Negative-QTOF | splash10-004r-4029300000-4a20781c329706bbf884 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 10V, Positive-QTOF | splash10-004i-0209330000-59e1dba24becca330d0c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 20V, Positive-QTOF | splash10-004i-0009000000-e33d3318ffd9d0bbb6a7 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clozapine glucuronide 40V, Positive-QTOF | splash10-004i-0179100000-05628b813c56def5c4c2 | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|